Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

5-methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide sodium salt

EU orphan designation number: EU/3/03/182   
Active ingredient: 5-methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide sodium salt
Indication: Treatment of aneurysmal subarachnoid haemorrhage
Sponsor: Idorsia Pharmaceuticals Deutschland GmbH
Wallbrunnstraße 24, 79539 Lörrach, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2003 Orphan designation EMEA/OD/057/03 (2003)5039 of 12/12/2003
10/01/2005 Transfer of orphan designation EMEA/OD/057/03/T/01 (2004)5731 of 06/01/2005
02/07/2014 Change of name and/or address of sponsor
07/09/2017 Transfer of orphan designation EMEA/OD/057/03/T/02 (2017)6106 of 05/09/2017